Drug Profile
Mitumprotimut T
Alternative Names: B cell lymphoma vaccine - Favrille; FavId; Id-KLH vaccine; Non-Hodgkin's lymphoma vaccine - Favrille; SpecifidLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Favrille
- Class Cancer vaccines
- Mechanism of Action B cell modulators; Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- Available For Licensing Yes
Highest Development Phases
- Discontinued Follicular lymphoma; Non-Hodgkin's lymphoma
Most Recent Events
- 30 Nov 2011 Mitumprotimut T is available for licensing as of 30 Nov 2011. www.mmrvideos.com
- 15 Jun 2010 MMR Information Systems is now called MMRGlobal
- 31 Jan 2009 MMR Information Systems acquires Favrille